Evidence map›Paper›PMID 41028417›Full record

ArticleCommunications chemistry2025

Real-time inline-IR-analysis via linear-combination strategy and machineś learning for automated reaction optimization.

Yosuke Ashikari, Takashi Tamaki, Kyosuke Tomite, Yuya Yonekura, Aiichiro Nagaki

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yosuke AshikariFaculty of Science, Hokkaido University, Sapporo, Hokkaido, Japan.
Takashi TamakiGraduate School of Engineering, Kyoto University, Kyotodaigakukatsura, Nishikyo-ku, Kyoto, Japan.
Kyosuke TomiteFaculty of Science, Hokkaido University, Sapporo, Hokkaido, Japan.
Yuya YonekuraFaculty of Science, Hokkaido University, Sapporo, Hokkaido, Japan.
Aiichiro NagakiFaculty of Science, Hokkaido University, Sapporo, Hokkaido, Japan. nagaki@sci.hokudai.ac.jp.ORCID http://orcid.org/0000-0002-8264-6205

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) JP20K15276MEXT | Japan Society for the Promotion of Science (JSPS) JP20KK0121MEXT | Japan Society for the Promotion of Science (JSPS) JP21H01706MEXT | Japan Society for the Promotion of Science (JSPS) JP23K21114MEXT | Japan Society for the Promotion of Science (JSPS) JP24K08421MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR18R1New Energy and Industrial Technology Development Organization (NEDO) JNPN14004New Energy and Industrial Technology Development Organization (NEDO) JPNP19004
6 · The paper itself

Abstract

Automation has revolutionized many fields by improving efficiency, accuracy, and reproducibility. However, in organic chemistry, automating key tasks such as reaction optimization and analysis remains a significant challenge. To accelerate advancements in organic chemistry research and development, we propose a fully automated system based on real-time inline analysis performed by Fourier-transform infrared spectroscopy and assisted by a neural network model. To rapidly collect data, a linear combination of spectral intensities was used as training data for a yield prediction model. Using this model, we demonstrated real-time yield prediction of Suzuki-Miyaura cross-coupling with remarkable accuracy. By combining this yield prediction model with real-time inline analysis and a flow chemistry setup, we have developed a fully automated system for the rapid and efficient optimization of reaction conditions and process analysis.

Identifiers

PMID41028417
PMCPMC12484558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.